What antihypertensive agents can be used instead of hydrochlorothiazide for a male patient with hypertension that do not cause erectile dysfunction?

Optimal Antihypertensive Alternatives to HCTZ for Preserving Erectile Function

For men with hypertension concerned about erectile dysfunction, switch to an angiotensin-receptor blocker (ARB) as first-line therapy, as ARBs are associated with neutral or even beneficial effects on erectile function and represent the most favorable antihypertensive class for preserving sexual health. 1

Preferred First-Line Agents (Listed by Strength of Evidence)

Angiotensin-Receptor Blockers (ARBs) — BEST CHOICE

• ARBs demonstrate neutral or beneficial effects on erectile function and should be your first choice when replacing HCTZ. 1
• Valsartan specifically increased sexual activity from 1.0 to 1.6 times per week in a large study of 1,899 hypertensive men, while conventional therapy decreased activity. 2
• Irbesartan significantly improved erectile function in 1,069 hypertensive patients with metabolic syndrome. 1

ACE Inhibitors — EXCELLENT ALTERNATIVE

• ACE inhibitors have not been shown to increase the incidence of erectile dysfunction and are considered safe alternatives for men concerned about sexual function. 1
• Multiple controlled trials show no increased ED incidence compared to placebo. 3
• These agents may even be protective compared to diuretics or beta-blockers through favorable effects on endothelial function. 3

Calcium-Channel Blockers — SAFE OPTION

• Calcium-channel blockers demonstrate neutral effects on erectile function and do not raise the risk of erectile dysfunction. 1
• Amlodipine showed no statistical difference in sexual dysfunction compared to placebo in randomized controlled trials. 4

Beta-Blocker Consideration (If Clinically Required)

• If a beta-blocker is medically necessary, prescribe nebivolol exclusively, as it is a vasodilating β-blocker significantly less likely to cause erectile dysfunction compared with traditional β-blockers. 1
• Traditional β-blockers (excluding nebivolol) have well-documented negative effects on libido and erectile function and should be avoided. 1, 5

Critical Context About HCTZ and ED Risk

Dose-Dependent Relationship

• Thiazide diuretics at higher daily doses (>50 mg hydrochlorothiazide or >25 mg chlorthalidone) are linked to markedly higher incidence of erectile dysfunction. 1
• The TOMHS trial documented 17.1% incidence of erection problems at 24 months with chlorthalidone versus 8.1% with placebo. 3
• One study found 56% sexual dysfunction rate in men taking 25-50 mg daily HCTZ for at least 6 months, compared to 11% in unmedicated controls. 6

Important Nuance

• Recent evidence suggests the negative impact of thiazides may be less pronounced than historically reported, particularly at lower doses. 5
• Short-term exposure (6-14 weeks) to low-dose HCTZ (6.25-25 mg) showed no statistical difference in sexual dysfunction compared to placebo. 4

Management Algorithm

Step 1: Switch the Offending Medication FIRST

• Replace HCTZ with an ARB or ACE inhibitor before adding ED-specific treatment. 1, 7
• This approach addresses the root cause rather than masking symptoms with additional medications.

Step 2: If ED Persists After Medication Switch

• Add a phosphodiesterase-5 inhibitor (sildenafil, tadalafil, vardenafil), which can be safely co-administered with ARBs, ACE inhibitors, and calcium-channel blockers. 1, 7
• Absolute contraindication: Never combine PDE5 inhibitors with nitrates due to risk of severe, potentially fatal hypotension. 7

Step 3: Assess for Non-Medication Causes

• Hypertension itself causes endothelial dysfunction that contributes to ED independent of medication effects. 1, 7
• Approximately 40% of hypertensive men experience ED, often related to the disease process rather than treatment. 1
• ED may serve as an early marker of cardiovascular risk, warranting comprehensive cardiovascular evaluation. 1, 7

Common Pitfalls to Avoid

• Do not assume all ED in hypertensive patients is medication-related—the underlying vascular disease frequently contributes. 7
• Do not use mineralocorticoid receptor antagonists (e.g., spironolactone) as alternatives, as they may adversely affect erectile function. 1
• Do not fail to assess baseline sexual function before initiating any antihypertensive therapy, as this allows proper attribution of subsequent changes. 1

Practical Prescribing Recommendation

Start with an ARB (such as valsartan 80-160 mg daily, losartan 50-100 mg daily, or irbesartan 150-300 mg daily) when discontinuing HCTZ. 1, 2 If ARBs are contraindicated or not tolerated, use an ACE inhibitor (such as lisinopril 10-40 mg daily or perindopril 4-8 mg daily) as your second choice. 1, 3 Reserve calcium-channel blockers as a third option if the first two classes cannot be used. 1